(RTTNews) - bluebird bio, Inc. (BLUE) has commenced an underwritten public offering of 20 million shares of its common stock. The company intends to grant the underwriters a 30-day option to purchase ...
SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results